CLINICAL_TRIALS
trial_result
· 2021-12-21
Clinical Trial Update: Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents [Phase 1, Phase 2]
Summary
Clinical trial update for plus epicatechin in non-ambulatory adolescents with Duchenne muscular dystrophy, completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Craig McDonald, MD | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-12-21